Allan Will, Chairman of the Board, President & CEO – Allan is an operating executive with extensive experience founding, funding, operating, and selling medical device companies. Prior to EBR, he led negotiation of Ardian’s acquisition by Medtronic for over $800M. Will was also founding Managing Director, Split Rock Partners and a Partner at St. Paul Venture Capital. Previously, he was Founder, Chairman & CEO of The Foundry, co-founding 11 companies there including Ardian, Evalve (acquired by Abbott Laboratories for $450M) & Concentric Medical (acquired by Stryker for $135M). Previously, Will was CEO of AneuRx, acquired by Medtronic, growing to >$150MM the year of launch. In 1996 Will co-founded Adjacent Surgical, sold to GSII. Previously, he was President & CEO of Devices for Vascular Intervention, growing the business to 550 employees, $100MM revenue run rate, and acquisition by Eli Lilly. Will is an inventor on more than 30 issued patents, and has his M.S. in Management from MIT and his B.S. in Zoology from University of Maryland. Will has also served on MIT’s Entrepreneurship Center Shareholders Board, on the University of Maryland President’s Committee on Innovation and Entrepreneurship and is a University of Maryland “Distinguished Alumnus”. Will was the recipient of the Astia/Deloitte Leadership in Mentoring Award for mentoring women executives.
Chairman of the Board,
President & CEO
Rick Riley, COO Australia & Co-Founder – Rick has an extensive medical device development background with experience in a wide range of devices used in electrophysiology including pacemakers, defibrillators, CRM programmers, catheters, ablation energy technologies, and imaging and electro-mapping systems. He brings a strong management background to the team, including executive positions at Boston Scientific, Cardiac Pathways and Medtronic and as the Founding CEO of EBR Systems. Riley is an inventor on more than 25 issued patents, and has his M.S. in Industrial and Management System Engineering from Arizona State University and his B.S. in Computer Science from University of Kansas.
Vice President of Field Engineering & Co-Founder
Spencer H. Kubo, M.D., Chief Medical Officer – Spencer joined EBR in January 2019 as Chief Medical Officer. He is also Chief Medical Officer for Heart Leaflet Technologies where he leads the clinical trials for a next generation Transcatheter Aortic Valve Replacement (TAVR). Dr. Kubo has extensive experience developing innovative cardiovascular devices including neuromodulation, mitral regurgitation and cardiac support.
Dr. Kubo has also served as Executive Director of Merck, leading the Academic and Professional Affairs department. Prior to that, Dr. Kubo was Professor of Medicine, Co-Director of Clinical Cardiology and Medical Director of the Heart Failure-Heart Transplantation Program at the University of Minnesota.
Dr. Kubo is widely regarded as a leading researcher in heart failure and has published more than 250 papers and abstracts.
Dr. Kubo graduated from Dartmouth College and received his MD from Cornell University Medical College. He is a Fellow of the American College of Cardiology and the American Heart Association.
Dr. Kubo maintains a part-time outpatient practice at United Heart and Vascular Clinic in St. Paul, Minnesota.
Spencer H. Kubo, M.D.
Chief Medical Officer
Suzanne Pilkington, Chief Financial Officer, VP Finance, Head of Human Resources – Suzanne has over 30 years of experience in Finance & HR roles, and 15 years of senior leadership experience in high-tech startup environments. She has led the strategic direction of finance, accounting, operations, revenue and HR, while building teams and developing scalable processes, across multiple industries including data storage devices, computer hardware peripherals, digital media and legal & private wealth services. Suzanne co-led and was the financial authority during the recent acquisition of Yummly, Inc. by Whirlpool Corporation. She has been an invited speaker at leadership and women in technology events. Suzanne holds her B.S. in Business Administration/Accounting from San Jose State University.
Chief Financial Officer, VP Finance and Administration
N. Parker Willis, Ph.D., Chief Technical Officer – Parker is an electrical engineer with extensive experience in signal processing applications and has worked in medical devices for over 20 years, all in technical leadership capacities for development of novel technologies for cardiac electrophysiology. He previously held senior positions at Boston Scientific and Cardiac Pathways. Willis is an inventor on more than 28 issued patents, and has his B.Sc. in Electrical Engineering from the University of California, San Diego and his M.Sc. and Ph.D. from the University of Illinois Urbana Champaign.
N. Parker Willis, Ph.D.
Chief Technical Officer
Madhuri Bhat, Vice President of Regulatory Affairs – Madhuri has over 20 years of experience in public affairs, public policy, clinical, quality, and regulatory roles in medical devices. She led several successful pivotal clinical trials and multiple registries, and secured regulatory approvals and clearances in the US and internationally for Class II and III cardiovascular systems. Most recently, Madhuri served as Consulting Vice-President RA/Clinical for companies in the reproductive, GI, neurological, urological, and cardiovascular domains such as Kyma Medical (acquired by Zoll) as the Founder / Principal of her own consulting company. Prior to that, Madhuri was the VP of RA/QC at Barrx Medical (acquired by Covidien, then Medtronic), VP of RA/Clinical at Corventis (acquired by Medtronic), and held management positions at Guidant and Abbott Vascular. Madhuri is a book author on child advocacy, and serves as visiting faculty at San Jose State University. She has a B.S. in Biology from University of Mumbai, a diploma in Mass Communications from Sophia Polytech, and a Master’s in Public Policy from Duke University.
Vice President of Regulatory Affairs
Brandi Johnson, Vice President of Clinical, Quality and Compliance – Brandi Johnson brings over 15 years of experience in designing and implementing clinical trials involving novel medical devices. Ms. Johnson has managed all sizes and phases of studies, ranging from early first-in-human trials to large, randomized, international studies that formed the basis for regulatory approval. Her experiences across multiple fields such as orthopedics, ophthalmology, and cardiovascular and pulmonary therapies allow her to integrate best practices from all these areas into each new trial she manages. This depth of knowledge stems from prior work experiences at companies including InterVene, Cotera, Ivantis, Medtronic, Ardian, Emphasys Medical and DexCom. Ms. Johnson holds a B.S. in Genetics from the University of Wisconsin-Madison.
Vice President of Clinical, Quality and Compliance
Christopher Pfaff, Vice President of Marketing – Chris has over 20 years of experience in marketing, market development and clinical research roles. He has led successful therapy development, market launch and commercial marketing efforts in the cardiology, hypertension and orthopaedics markets. Prior to EBR, Chris held positions at Ceterix Orthopaedics, Medtronic, Ardian (acquired by Medtronic), Johnson and Johnson and Guidant (acquired by Abbott) in addition to strategy consulting. He received his BS and MS in Mechanical Engineering from the University of California at Berkeley and his MBA from the Kellogg School of Management at Northwestern University.
Vice President of Marketing
John Sam, Vice President, Operations – John has over 15 years of medical device experience and has managed, supported and transferred many different technologies and products from concept to commercialization. He started his career at Abbot Vascular Devices where he contributed to the successful integration of Perclose’s product lines to a larger organization. He later applied these concepts to the expansion of manufacturing at FoxHollow Technologies, which was acquired by Ev3 and is still being manufactured by Medtronic. Subsequently, he led the operational launch of electrosurgery devices at Ardian and tissue-based mitral valve replacements at Twelve (both technologies were acquired and transferred to Medtronic). John holds a B.S. in Mechanical Engineering from California Polytechnic San Luis Obispo and M.S. in Engineering Management from Santa Clara University.
Vice President of Operations
Andrew Shute, Senior Vice President of Field Operations – Andrew has over 20 years of medical device experience and has led the successful commercialization of new technologies and products working in the corporate, start-up and distributor settings. He brings strong business, clinical training and sales management background to the team, including positions at St. Jude Medical, Endocardial Solutions and Getz Brothers. Shute received his B.S. from the University of Wollongong, Australia. Shute currently holds the position of Chairman of the Cardiac Rhythm Management section of the Association of British Healthcare Industries Ltd (ABHI).
Senior Vice President of Field Operations
Mike Welch, Vice President of US Market Development – Mike has over 25 years of experience bringing first-of-kind medical device technologies to market. He has partnered with clinicians in over 40 countries to gather early clinical experience with novel devices. Mike went on to build and manage networks of direct sales forces and distributors to commercialize those devices once regulatory approval was obtained. Mike has served this role across numerous organizations ranging from small, early stage start-ups to large multinationals. His prior work experiences include Cotera, Relievant, Medtronic, Ardian, Emphasys and Abbott/Perclose. He is currently the VP of US Market Development for EBR Systems.
Vice President of US Market Development